Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE: 002755)
China flag China · Delayed Price · Currency is CNY
10.90
+0.09 (0.83%)
Sep 9, 2024, 1:35 PM CST

Beijing Aosaikang Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 2018 - 2014
Market Capitalization
10,14510,0437,37011,81512,12214,999
Upgrade
Market Cap Growth
9.78%36.27%-37.63%-2.53%-19.18%-
Upgrade
Enterprise Value
8,4178,4335,75710,47710,82113,679
Upgrade
Last Close Price
10.9310.827.9412.6012.7315.56
Upgrade
PE Ratio
119.47-67.62-33.0830.7316.3218.52
Upgrade
PS Ratio
6.186.963.943.803.203.32
Upgrade
PB Ratio
3.123.342.453.664.005.96
Upgrade
P/FCF Ratio
49.42-64.42-36.2627.2331.8441.03
Upgrade
P/OCF Ratio
24.45-377.99-139.5420.8120.8928.06
Upgrade
EV/Sales Ratio
5.095.843.073.372.863.03
Upgrade
EV/EBITDA Ratio
202.62-40.37-25.7026.1013.1114.70
Upgrade
EV/EBIT Ratio
-172.18-29.03-18.3833.8314.7716.23
Upgrade
EV/FCF Ratio
41.00-54.09-28.3224.1428.4237.41
Upgrade
Debt / Equity Ratio
0.030.040.020.000.01-
Upgrade
Debt / EBITDA Ratio
1.96--0.030.02-
Upgrade
Debt / FCF Ratio
0.40-0.79-0.280.030.05-
Upgrade
Asset Turnover
0.470.420.520.821.011.36
Upgrade
Inventory Turnover
1.831.801.731.781.581.65
Upgrade
Quick Ratio
3.424.626.055.693.572.21
Upgrade
Current Ratio
3.735.076.606.193.842.44
Upgrade
Return on Equity (ROE)
1.28%-6.89%-8.53%12.16%26.14%35.80%
Upgrade
Return on Assets (ROA)
-0.75%-5.23%-5.48%5.14%12.21%15.84%
Upgrade
Return on Capital (ROIC)
-0.87%-5.85%-6.20%6.15%16.44%24.15%
Upgrade
Earnings Yield
0.84%-1.48%-3.06%3.22%5.95%5.21%
Upgrade
FCF Yield
2.02%-1.55%-2.76%3.67%3.14%2.44%
Upgrade
Dividend Yield
0.00%--0.79%1.57%1.41%
Upgrade
Payout Ratio
1.28%--48.90%28.43%14.95%
Upgrade
Buyback Yield / Dilution
-19.51%1.34%-1.55%-0.16%0.49%-23.49%
Upgrade
Total Shareholder Return
-19.51%1.34%-1.55%0.64%2.06%-22.07%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.